Krystal Biotech Inc Stock News

Internationally renowned ophthalmologist, Gerd Auffarth, MD, ranked as one of the “100 most influential personalities in ophthalmology worldwide" in the...

If you own shares in Krystal Biotech, Inc. (NASDAQ:KRYS) then it's worth thinking about how it contributes to the...

Mar 30, 2020 (The Expresswire) -- Global "Malonic Acid Market" compromises many advantages that have accelerated the adoption of absorption among various...

Spark Therapeutics (NASDAQ:ONCE) and Krystal Biotech (NASDAQ:KRYS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their ins

Allakos (NASDAQ:ALLK) initiated with Underperform rating and $34 (42% downside risk) price target at SMBC Nikko.Avadel Pharmaceuticals (NASDAQ:AVDL) initiated with Buy rating and $14 (75% upside) pric

After Chardan Capital and H.C. Wainwright gave Krystal Biotech (NASDAQ: KRYS) a Buy rating last month, the company received another Buy, this time from

After Chardan Capital and H.C. Wainwright gave Krystal Biotech (NASDAQ: KRYS) a Buy rating last month, the company received another

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Krystal Biotech (KRYS) and Precision BioSciences (DTIL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Krystal Biotech

On the research front, our research, clinical and regulatory teams are working to initiate a Phase 1 clinical study in an aesthetic skin indication and file an IND for a third rare disease indication

“I’ve met so many unsung heroes and would like to take this opportunity to thank them for their continued commitment to those less fortunate than ourselves.”

Krystal Biotech announced changes to its financial leadership on Tuesday, including the resignation of its chief financial officer. The Pittsburgh-based biomedical firm said that CFO Tony Riley had r

Krystal also announced that Tony Riley has resigned as chief financial officer, effective Feb. 22, 2020. "As our corporate needs continue to evolve, particularly as we develop our research, clinical

PITTSBURGH, Feb. 21, 2020 -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients.

Feb 21, 2020 (The Expresswire) -- EV On-Board Chargers market report includes all the factors that will affect the market trends, drivers and challenges of...